<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00562029</url>
  </required_header>
  <id_info>
    <org_study_id>djb-2007</org_study_id>
    <nct_id>NCT00562029</nct_id>
  </id_info>
  <brief_title>Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes Mellitus</brief_title>
  <acronym>DJB</acronym>
  <official_title>Modified Duodenal Switch Procedure &quot;Duodenal-Jejunal Bypass&quot; (Diabetes Surgery) As A Potential Cure for Type 2 Diabetes Mellitus in Non-Obese Patients- a Pilot Project to Validate a Prospective Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sound Shore Medical Center of Westchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maffucci L, Rangraj M</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sound Shore Medical Center of Westchester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Premise: Complete resolution of Type 2 Diabetes Mellitus with normalization of blood glucose
      and HbA1c in the abscence of medication support is possible with a surgical procedure named
      the &quot;Duodenal-Jejunal Bypass (DJB)&quot; a modification of an established duodenal switch
      procedure and is performed utilizing the laparoscopic approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: The duodenum plays a major role in glucose homeostasis through mechanisms largely
      unknown at this time. Evidence of this hypothesis comes from accumulated data in bariatric
      surgery patients who underwent Roux-en-y Gastric Bypass or Biliopancreatic Diversion (BPD)
      with or without a Duodenal Switch. Current evidence strongly supports this hypothesis with a
      long term (over 10 years) Type 2 Diabetes Mellitus(T2DM) resolution rate of 84-86% following
      the gastric bypass and over 95% for the duodenal switch.

      The clinical resolution of T2DM is defined as independence of all anti-diabetic medications
      and maintaining a HbA1c less than 6.0. Recent rodent experiments by Francesco Rubino and
      subsequent human case reports by Cohen et al. supports the validity of this hypothesis. The
      modified procedure involved a roux-en-y bypass of the duodenum and 30-50cm of proximal
      jejunum, unaltering the stomach and pylorus resulted in resolution of T2DM with no weight
      loss in all subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure: Resolution of Type 2 Diabetes Mellitus</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure: Safety and efficacy of duodenal-jejunal bypass</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>DJB patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient has undergone a duodeno-jejunal bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duodenal-jejunal Bypass</intervention_name>
    <description>Patient has undergone a duodenal bypass and bypass of 60cm of proximal jejunum</description>
    <arm_group_label>DJB patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Established diagnosis of Type 2 diabetes mellitus

          -  Body Mass Index(BMI) less than 35

          -  Insulin usage duration less than 10 years

          -  Negative anti-GAD

          -  Fasting C-peptide level over 1.0 mcg/ml

          -  Ability and willingness to follow up for a period of 1 year

          -  Willingness to consent for utilizing personal results without individual identifier
             information to be published in medical studies and other media as determined by the
             study investigators

          -  Ability to understand and describe the risks, benefits and mechanism of action of the
             procedure

        Exclusion Criteria:

          -  Current pregnancy or positive pregnancy test

          -  Liver Cirrhosis

          -  Coagulopathy

          -  Type 1 Diabetes Mellitus

          -  HIV

          -  Previous abdominal surgery preventing laparoscopy

          -  Previous vagotomy

          -  Previous gastric or small intestine surgery

          -  Inability to comply with study requirements

          -  Currently active medical malpractice lawsuit/s

          -  Diseases of the exocrine pancreas: pancreatitis trauma, pancreatectomy, neoplasia,
             cystic fibrosis, hemochromatosis

          -  Endocrinopathies: acromegaly, glucagonoma, Cushing's Syndrome, pheochromocytoma,
             hyperthyroidism, somatostatinoma, aldorestanoma

          -  Chemical Induced Diabetes: vacor, pentamidine, nicotinic acid, glucocorticoids,
             thyroid hormones, diazoxide, beta-adrenergic agonists, thiazides, phenytoin,
             alfa-interferon

          -  Genetic Syndromes with Diabetes: Down's, Klinefelter's, Turner's, Wolfram,
             Lawrence-Moon- Beidel, Prader-Willi, Friederich's ataxia, Huntington's Chorea,
             Myotonic Dystrophy, Porphyria,

          -  If a candidate is deemed to be not an appropriate candidate based on investigators
             recommendation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonard Maffucci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sound Shore Medical Center of Westchester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Madhu S Rangraj, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sound Shore Medical Center of Westchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sound Shore Medical Center of Westchester</name>
      <address>
        <city>New Rochelle</city>
        <state>New York</state>
        <zip>10802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://ees.elsevier.com/soard/</url>
    <description>click here for information on background to present study</description>
  </link>
  <reference>
    <citation>Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006 Nov;244(5):741-9.</citation>
    <PMID>17060767</PMID>
  </reference>
  <reference>
    <citation>Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. Review. Erratum in: JAMA. 2005 Apr 13;293(14):1728.</citation>
    <PMID>15479938</PMID>
  </reference>
  <results_reference>
    <citation>Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007 Mar-Apr;3(2):109-15. Review.</citation>
    <PMID>17386391</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis. 2007 Mar-Apr;3(2):195-7.</citation>
    <PMID>17386401</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2007</study_first_submitted>
  <study_first_submitted_qc>November 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2007</study_first_posted>
  <last_update_submitted>May 19, 2015</last_update_submitted>
  <last_update_submitted_qc>May 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Surgery</keyword>
  <keyword>Duodenal Bypass</keyword>
  <keyword>Resolution</keyword>
  <keyword>Surgical Procedures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

